<DOC>
	<DOCNO>NCT01501032</DOCNO>
	<brief_summary>The purpose feasibility study evaluate MDLAP ( MD-Logic Artificial Pancreas system ) automate insulin management system use continuous glucose monitoring ( CGM ) subcutaneous insulin pump infusion individual type 1 diabetes . The study include 3 inpatient admission ( 12-24 hr ) , include overnight sleep , over-bolus meal , under-bolus meal exercise .</brief_summary>
	<brief_title>Inpatient Evaluation MD-Logic Artificial Pancreas System Patients With Type 1 Diabetes</brief_title>
	<detailed_description>The purpose feasibility study evaluate MDLAP ( MD-Logic artificial pancreas system ) automate insulin management system use continuous glucose monitoring ( CGM ) subcutaneous insulin pump infusion individual type 1 diabetes . The study include 3 inpatient admission ( 12-24 hr ) , include overnight sleep , over-bolus meal , under-bolus meal exercise . During visit , meal bolus semi-automated , manual meal announcement physician/nurse , automate bolus recommendation system , automate delivery bolus follow confirmation recommendation . Between-meal insulin dose fully automate . Bolus confirmation physician/nurse request close loop controller determines carbohydrate may necessary avoid hypoglycemia follow bolus .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Clinical diagnosis type 1 diabetes least one year use insulin pump least 6 month Age 12 65 year Hemoglobin A1c ( HbA1c ) 5.0 % 10.5 % , measure DCA2000 equivalent device For female , currently know pregnant Demonstration proper mental status cognition study An understanding willingness follow protocol sign inform consent assent Diabetic ketoacidosis past 6 month Severe hypoglycemia result seizure loss consciousness 12 month prior enrollment History seizure disorder ( except hypoglycemic seizure ) . Coronary artery disease heart failure . Cystic fibrosis Active infection A known medical condition judgment investigator might interfere completion protocol A recent injury body limb , muscular disorder , use medication , carcinogenic disease , significant medical disorder injury , medication disease judgment investigator affect completion exercise protocol Current use beta blocker medication Hematocrit &lt; 30 % Use pseudoephedrine 48 hour prior Clinical Research Center ( CRC ) admission</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Diabetes Type 1</keyword>
	<keyword>Artificial Pancreas</keyword>
</DOC>